TLPH Stock Analysis: Buy, Sell, or Hold?
TLPH - Talphera, Inc. Common Stock
$1.33
0.05 (3.91%)
▲
5d:
+5.56%
30d:
+24.3%
90d:
+44.79%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 13, 2026
8d
Get Alerted When TLPH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: TLPH shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: TLPH shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: TLPH is currently trading at $1.33, which is considered slightly high relative to its 30-day fair value range of $1.13 to $1.39.
Technical Outlook: Technically, TLPH is in a strong uptrend. Immediate support is located at $1.22, while resistance sits at $1.43. The stock is showing strong short-term momentum, up 3.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.17 (+138.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TLPH is in a strong uptrend. Immediate support is located at $1.22, while resistance sits at $1.43. The stock is showing strong short-term momentum, up 3.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.17 (+138.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$1.13 -
$1.39
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.1%
All Signals
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.9%)
- BULLISH: Trading 138.1% below Wall St target ($3.17)
Trading Range Analysis
30-Day Trading Range
$1.13 -
$1.39
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$1.22
Resistance Level
$1.43
Current Trend
Strong Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.93
Wall Street Target
$3.17
(+138.1%)
Share & Embed Analysis
Last updated: August 03, 2026 9:10 PM ET
Data refreshes hourly during market hours. Next update: 10:10 PM
Data refreshes hourly during market hours. Next update: 10:10 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TLPH showing a specific setup today?
Insider Activity (6 Months)
5
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Vincent J Angotti
BUY
213310 shares
2026-03-13
Badri N Dasu
BUY
35000 shares
2026-02-12
Raffi Asadorian
BUY
45000 shares
2026-02-12
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$211 | 60 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$112 | 52 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$663 | 48 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$113 | 45 HOLD |
|
AVDL
Avadel Pharmaceuticals P… |
STRONG BUY
8 analysts |
$21 | 62 BUY |
